Compound ID | 2811
Class: Natural product antibiotic
Spectrum of activity: | Gram-positive |
Details of activity: | Active against methicillin-resistant Staphylococcus aureus; antibiotic resistance determinant Cfr inhibitor (Cfr-dependent activity; inhibits methylation of residue A2503 of 23S rRNA) |
Description: | Natural product from Streptomyces WAC01849; potentiates PhLOPSa antibiotics (not observed when cfr is absent); speculated to be intermediate product of a kiamycin-like compound |
Institute where first reported: | Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada |
Year first mentioned: | 2023 |
Development status: | Experimental |
Chemical structure(s): | |||||||||||
|
|
External links: | |
Citation: | https://journals.asm.org/doi/10.1128/mbio.01791-23 |